ADVE RTI S ING F EATUR E
From 0 to 1,000: the past, present and future of ultrasound probe HLD
Nanosonics is celebrating the installation of the 1,000th Trophon®
device in the UK.
Nanosonics’ Trophon technology is a market leader in automated ultrasound reprocessing systems delivering consistent high level disinfection (HLD) of ultrasound probes. Manufactured in Sydney, Australia, this innovation made its way across to the UK in 2013, with the first UK device installed at Kings Mill Hospital, thanks to funding from the Sherwood Forest NHS Trust. Coming full circle, in 2021 the UK Nanonsonics team has hit their milestone 1,000th Trophon device installation with the same hospital that took the important first steps in recognising the importance of automated HLD for ultrasound probes. Nanosonics UK would like to thank all who have contributed to this achievement and recognise the valuable impact this has had on improving patient care by driving positive best practice change for how ultrasound probes are processed and decontaminated. Since the first Trophon device launched in July 2013, there has been significant
updates to the published guidance on the reprocessing of ultrasound probes in Wales, Scotland and Northern Ireland. It is now recommended in guidance that HLD and automation should be used when reprocessing semi-critical ultrasound probes. In England, the College Society of Radiographers (CSoR) and British Medical Ultrasound Society (BMUS) have taken this one step further by stating that automation is the preferred best practice for ultrasound probe decontamination.
“Disinfectant-impregnated wipes that contain an effective disinfectant are widely used but the assurance that all surfaces are in contact with liquid disinfectant for the required time is not as easy to achieve as a high-quality assurance standardised and automated process. Therefore, best practice is the use of an automated system” (AXREM, BMUS, SCoR 20211
)
Louise Cordon, lead sonographer at Kings Mill Hospital (see p7; above, right of Trophon device) sat down with Bryn Tudor Owen, Nanosonics UK Country Manager (above, left of Trophon device) to discuss why they chose and continue to choose Trophon technology across the Sherwood Forest NHS Trust. She explained: “We chose Trophon primarily due to its ease of use – it provides high level disinfection at the touch of a button.” When asked about the main benefits she saw from installing Trophon technology, she outlined the following: l How user friendly it is l The easy installation and maintenance of the technology
l Reductions in exposure to chemicals and spills due to the system being sealed
l Its cleanliness and efficiency l The speed of the disinfection cycle – giving back 7 minutes to the operation to fulfil other tasks such as room prep and patient notes
l The built-in failsafe features such as the chemical indicator
Following an upgrade to the latest trophon2 technology, Ms Cordon pointed out additional benefits such as “improved traceability with AcuTraceTM
, improved probe placement 6 l
WWW.CLINICALSERVICESJOURNAL.COM VOLUME 21 l ISSUE 1 l JANUARY 2022 THE CLINICAL SERVICES JOURNAL
Tackling the barriers to reducing SSIs
Theatres: working smarter not harder Decontamination: the challenges ahead in 2022
W W W. C L I N I C A LS E R VI C E S JO U R N A L . C O M
within the system, reduction in the number of manual steps and the reduction in user error thanks to the fully automated process.” Looking to the future, Ms Cordon “acknowledges the government-led initiative of the development of diagnostic treatment centres within the community setting, with an increase in more specialist and interventional procedures developing within the hospital setting.”
Therefore, she recommended that “having a reliable disinfection system increases productivity and is vital in providing a safe, efficient service to our patients and healthcare colleagues.
“If you’re looking for a reliable, traceable, efficient and safe method of probe disinfection, Trophon may be the answer for you, so give it a go!”
The achievement of the 1,000th
Trophon installation in the UK reflects the acknowledgement of Trophon technology becoming the Global Standard of Care for ultrasound probe HLD.
As awareness grows about the risks associated with not disinfecting ultrasound probes appropriately, so too does the installation rates of Trophon technology across the globe. In fact, Trophon devices
JANUARY 2022
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84
